Traws Pharma Enters Stock Purchase Agreement With Roth Principal Investments On Oct 23, 2026; May Sell Up To $50M In Common Stock To Roth Principal Investments

Loading news article.

Traws Pharma Enters Stock Purchase Agreement With Roth Principal Investments On Oct 23, 2026; May Sell Up To $50M In Common Stock To Roth Principal Investments | WAPE

Traws Pharma Enters Stock Purchase Agreement With Roth Principal Investments On Oct 23, 2026; May Sell Up To $50M In Common Stock To Roth Principal Investments

Article summary

Related companies

Analyzed by WAPE AI.

Comments —